Using Nevisense to help diagnose skin cancer
Part of Cancer, Skin clinical trials.
This study tests a device called Nevisense that helps doctors check if a suspicious skin spot is a type of skin cancer called keratinocyte cancer (including basal cell carcinoma, squamous cell carcinoma, and related conditions like actinic keratosis). If you have a spot that your doctor is unsure about, this tool may help get a clearer answer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a skin spot that your doctor is unsure about and suspects could be keratinocyte skin cancer
- The spot is not on your palms, soles, scalp, beard, mustache, genitals, or inside your ears or under nails
- The spot is not on a scar, crust, psoriasis patch, or sunburn
- The spot has not been biopsied, treated with surgery, or injured before
- The spot is not on a tattoo, splinter, or other foreign object
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways of marking skin before removing a non-melanoma skin cancer: using a special magnifying tool called a dermoscope versus the standard method. The goal is to see which method helps remove the cancer completely the first time.
This trial tests a personalized aftercare report for people with low-risk skin cancer. It aims to see if this report can improve follow-up care.
This study is looking at how well a new skin imaging tool called LC-OCT works in everyday skin cancer clinics in the Netherlands. It will help doctors understand if this tool can accurately identify skin cancers without needing as many biopsies.
This study is testing a handheld device that scans skin lesions to help detect melanoma. If you have a spot that your doctor thinks could be melanoma, this study will see how well the device works compared to standard checks.
This trial is testing a special light-based technique (Raman spectroscopy) to see if it can help doctors better identify skin cancers. It is for people with either basal cell or squamous cell carcinoma who are scheduled to receive brachytherapy treatment.
This study looks at skin spots that might be unusual moles or early melanoma using a special microscope that sees deep into the skin. It aims to match these microscope images with genetic information to better understand these spots.
Hear when a new Keratinocyte Skin Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.